573 results on '"McGoon, Michael D."'
Search Results
2. Thrombocytopenia independently predicts death in idiopathic PAH
3. Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL
4. Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis
5. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance
6. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis
7. Physician attitudes toward palliative care for patients with pulmonary arterial hypertension: results of a cross-sectional survey
8. Characterization of First-Time Hospitalizations in Patients With Newly Diagnosed Pulmonary Arterial Hypertension in the REVEAL Registry
9. Hemodynamic Ranges During Daily Activities and Exercise Testing in Patients With Pulmonary Arterial Hypertension
10. Four- and Seven-Year Outcomes of Patients With Congenital Heart Disease–Associated Pulmonary Arterial Hypertension (from the REVEAL Registry)
11. Updated Treatment Algorithm of Pulmonary Arterial Hypertension
12. Pulmonary Arterial Hypertension: Epidemiology and Registries
13. 69-Year-Old Woman With Ascites, Hypoxia, and Weight Loss
14. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: Insights from the REVEAL Registry
15. Impact of age on pulmonary artery systolic pressures at rest and with exercise
16. Role of Serial Quantitative Assessment of Right Ventricular Function by Strain in Pulmonary Arterial Hypertension
17. Characterization of Prostacyclin-associated Leg Pain in Patients with Pulmonary Arterial Hypertension
18. Diagnostic Dilemmas in Pulmonary Hypertension
19. Sex Differences in the Diagnosis, Treatment, and Outcome of Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management
20. The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
21. Delay in Recognition of Pulmonary Arterial Hypertension: Factors Identified From the REVEAL Registry
22. Right Ventricular Strain for Prediction of Survival in Patients With Pulmonary Arterial Hypertension
23. Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial Hypertension
24. The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States: How REVEAL Differs From Historic and Non-US Contemporary Registries
25. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia
26. Five-Year Outcomes of Patients Enrolled in the REVEAL Registry
27. Clinical Trials for Pulmonary Hypertension in the Developing World: Pulmonary Vascular Disease: The Global Perspective
28. Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry
29. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association
30. Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
31. Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension
32. Pulmonary hypertension: diagnosis and management
33. Evaluation of the Predictive Value of a Clinical Worsening Definition Using 2-Year Outcomes in Patients With Pulmonary Arterial Hypertension: A REVEAL Registry Analysis
34. Pericardial Effusions in Pulmonary Arterial Hypertension: Characteristics, Prognosis, and Role of Drainage
35. Pulmonary hypertension in patients with interstitial lung diseases
36. Functional Class Improvement and 3-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry
37. Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension: A REVEAL Registry Analysis
38. Demographics and Outcomes of Patients Diagnosed With Pulmonary Hypertension With Pulmonary Capillary Wedge Pressures 16 to 18 mm Hg: Insights From the REVEAL Registry
39. An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
40. Portopulmonary Hypertension: A Report From the US-Based REVEAL Registry
41. Survival in Pulmonary Hypertension Registries
42. REVEAL Registry: Correlation of Right Heart Catheterization and Echocardiography in Patients With Pulmonary Arterial Hypertension
43. Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination Survey
44. Incidence and predictors of cardiac perforation after permanent pacemaker placement
45. Treatment and Survival in Patients with Pulmonary Arterial Hypertension (PAH): 057.
46. Pulmonary arterial hypertension: current therapeutic strategies
47. Unexplained Pulmonary Hypertension in Elderly Patients*
48. Portopulmonary hypertension: Results from a 10-year screening algorithm
49. ARIES-1: A PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF AMBRISENTAN IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION
50. The Prognostic Value of Pulmonary Vascular Capacitance Determined by Doppler Echocardiography in Patients with Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.